Walleye Capital LLC Fibrogen Inc Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $65,023 - $86,877	4,900 New	4,900 $78,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $107,180 - $211,416	-4,600 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $266,266 - $370,062	-7,700 Reduced 62.6%	4,600 $197,000
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $11,093 - $14,535	300 Added 2.5%	12,300 $455,000
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $421,560 - $666,360	12,000 New	12,000 $542,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.